Chicago-based hospital bed and medical device supplier Hill-Rom Holdings appointed John Groetelaars president and CEO, effective May 14.
Groetelaars succeeds John Greisch, who previously announced in January his intention to retire. Groetelaars will also join Hill-Rom's board of directors, and Greisch, 62, will leave the board.
Groetelaars, 52, is a veteran in the medical device industry, with more than 25 years of experience. He most recently served as president of the interventional unit at New Jersey-based Becton Dickinson, and previously served in a variety of roles at new-Jersey based C.R. Bard. He received a bachelor's degree in mechanical engineering from Kettering University in Flint, Mich., and an MBA from Columbia University in New York.
Hill-Rom also announced its financial results for the fiscal second quarter ended March 31: Its profit fell 16 percent year over year, according to SEC filings. The company posted a profit of $28.5 million, or 42 cents a share, for the quarter ended, compared with $34 million, or 51 cents a share, for the same period last year.